Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Armstrong

Showing results (251-260 of 281) with videos related to

Pageof 29
Sort By:
Journal of the American College of Cardiology|June 1, 1996
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 InvestigatorsL K Newby, W R Rutsch, R M Califf, et al.
Circulation|July 9, 2003
Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarctionL Wallentin, P Goldstein, P W Armstrong, et al.
Heart (British Cardiac Society)|June 17, 2005
Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patternsP Kaul, L K Newby, Y Fu, et al.
The American Journal of Cardiology|December 30, 1999
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary ArteriesE M Ohman, P W Armstrong, H D White, et al.
Clinical Chemistry|March 25, 1998
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa InvestigatorsR H Christenson, S H Duh, L K Newby, et al.
Journal of the American College of Cardiology|January 15, 2000
Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarctionD Hasdai, R M Califf, T D Thompson, et al.
Journal of the American College of Cardiology|September 19, 1998
Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary ArteriesM Pfisterer, J L Cox, C B Granger, et al.
European Heart Journal|April 1, 1999
Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary ArteriesD Hasdai, D R Holmes, E J Topol, et al.
The New England Journal of Medicine|March 16, 2000
Cost effectiveness of early discharge after uncomplicated acute myocardial infarctionL K Newby, E L Eisenstein, R M Califf, et al.
European Heart Journal|December 1, 2001
Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PAF Van de Werf, H V Barron, P W Armstrong, et al.
Pageof 29

Showing results (251-260 of 281) with videos related to

Sort By:
Pageof 29
Journal of the American College of Cardiology|June 1, 1996
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 InvestigatorsL K Newby, W R Rutsch, R M Califf, et al.
Circulation|July 9, 2003
Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarctionL Wallentin, P Goldstein, P W Armstrong, et al.
Heart (British Cardiac Society)|June 17, 2005
Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patternsP Kaul, L K Newby, Y Fu, et al.
The American Journal of Cardiology|December 30, 1999
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary ArteriesE M Ohman, P W Armstrong, H D White, et al.
Clinical Chemistry|March 25, 1998
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa InvestigatorsR H Christenson, S H Duh, L K Newby, et al.
Journal of the American College of Cardiology|January 15, 2000
Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarctionD Hasdai, R M Califf, T D Thompson, et al.
Journal of the American College of Cardiology|September 19, 1998
Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary ArteriesM Pfisterer, J L Cox, C B Granger, et al.
European Heart Journal|April 1, 1999
Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary ArteriesD Hasdai, D R Holmes, E J Topol, et al.
The New England Journal of Medicine|March 16, 2000
Cost effectiveness of early discharge after uncomplicated acute myocardial infarctionL K Newby, E L Eisenstein, R M Califf, et al.
European Heart Journal|December 1, 2001
Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PAF Van de Werf, H V Barron, P W Armstrong, et al.
Pageof 29